What is the price target for YCBD stock?
7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 199.96% is expected in the next year compared to the current price of 0.6801.
NYSEARCA:YCBD • US12482W4087
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CBDMD INC (YCBD).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-20 | Maxim Group | Maintains | Buy -> Buy |
| 2025-05-22 | Maxim Group | Maintains | Buy -> Buy |
| 2023-10-05 | Maxim Group | Initiate | Buy |
| 2021-06-18 | Cantor Fitzgerald | Reiterate | Neutral |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 24.155M -31.76% | 19.482M -19.35% | 19.191M -1.50% | 21.627M 12.70% | 23.141M 7.00% | |
| EBITDA YoY % growth | -7.468M 51.76% | -2.166M 71.00% | -1.037M 52.14% | N/A | N/A | |
| EBIT YoY % growth | -9.269M 46.46% | -3.315M 64.23% | -2.163M 34.77% | -1.497M 30.76% | -550.8K 63.22% | |
| Operating Margin | -38.37% | -17.02% | -11.27% | -6.92% | -2.38% | |
| EPS YoY % growth | N/A | -13.84 73.42% | -4.04 70.81% | -0.14 96.47% | -0.07 50.00% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.05 97.32% | -0.04 80.57% | -0.05 70.00% |
| Revenue Q2Q % growth | 5.398M 13.66% | 5.495M 19.28% | 5.617M 19.00% |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -429.42K 11.61% | -379.44K 58.06% | -396.78K 42.14% |
All data in USD
7 analysts have analysed YCBD and the average price target is 2.04 USD. This implies a price increase of 199.96% is expected in the next year compared to the current price of 0.6801.
CBDMD INC (YCBD) will report earnings on 2026-05-13.
The consensus EPS estimate for the next earnings of CBDMD INC (YCBD) is -0.05 USD and the consensus revenue estimate is 5.40M USD.
The consensus rating for CBDMD INC (YCBD) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.